Orthofix Weighed Down by Management Vacancies and Order Delays

Orthofix reported 3Q19 revenue of USD $113.5MM, +1.6% vs. 3Q18.

The company has lowered full year 2019 revenue guidance to the range of $460MM (+1.5%) to $463MM (+2.2%)
Jon Serbousek will succeed Brad Mason as President and CEO on November 1, 2019
While biologics and the U.S. rollout of the M6 cervical disc were positives...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us